BRIEF published on 09/16/2025 at 18:05, 4 months 15 days ago ABIVAX: Distribution of Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 09/16/2025 at 10:04, 4 months 15 days ago JP Morgan Chase exceeds 5% threshold in ABIVAX Capital Actions Abivax Threshold Crossing JP Morgan Chase
BRIEF published on 09/12/2025 at 17:50, 4 months 19 days ago Abivax Joins CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology Abivax SBF 120 CAC Mid 60
PRESS RELEASE published on 09/12/2025 at 17:45, 4 months 19 days ago Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Abivax to join CAC Mid 60 and SBF 120 Indices on Euronext Paris following annual review, enhancing visibility and investor base Euronext Paris Abivax SBF 120 Index Inclusion CAC Mid 60
BRIEF published on 09/08/2025 at 22:05, 4 months 23 days ago Abivax Reports First Half 2025 Financial Performance Financial Results Research And Development Convertible Notes Public Offering Cash Reserves
PRESS RELEASE published on 09/08/2025 at 22:00, 4 months 23 days ago Abivax Presents First Half 2025 Financial Results Abivax presents first half 2025 financial results, revealing operating loss increase and net loss for the period, also updates on clinical programs and public offering Financial Results Abivax Public Offering Clinical Programs Operating Loss
BRIEF published on 09/02/2025 at 11:00, 4 months 29 days ago JP Morgan Chase & Co. Crosses Threshold at ABIVAX Voting Rights Capital Abivax Threshold Crossing JP Morgan
BRIEF published on 08/13/2025 at 18:05, 5 months 19 days ago ABIVAX: Update on capital and voting rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 5 months 19 days ago ABIVAX: Share and voting rights data as of July 31, 2025 Euronext Paris Voting Rights Biotechnology Actions AMF Regulations
BRIEF published on 07/28/2025 at 22:20, 6 months 4 days ago Abivax Completes $747.5 Million Public Offering Biotechnology Abivax Ulcerative Colitis Nasdaq Public Offer
Published on 01/31/2026 at 03:15, 1 day 19 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 21 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 23 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 02/01/2026 at 20:25, 2 hours 26 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 6 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 10 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 20 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 2 days ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 17:45, 2 days 5 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 3 days 4 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 3 days 5 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 3 days 5 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
